home about animi-3 Skip Navigation Links
deficienciesExpand deficiencies
healthcare professionals research contact


Animi-3 Press Contact

Joe Shields
Director of Public Relations
PBM Products, LLC
204 North Main Street
Gordonsville, VA 22942

tel
800.959.2066 x131

email
 jshields@pbmproducts.com


Animi-3 Press Room
Monday, April 21, 2008
Pregnant Women Need Omega-3 to Boost Infant Development
A new study funded by Health Canada and other organizations has proven a direct correlation between dietary consumption of the omega-3 DHA* and enhanced infant development.

Wednesday, August 29, 2007
European Experts Recommend Pregnant and Nursing Women Take More DHA – Every Day
More than 50 nutritional experts from an EU committee now recommend pregnant and nursing women supplement their diets on a daily basis with a large amount of DHA, an essential omega-3 fatty acid.
Wednesday, August 08, 2007
The Omega-3 Fatty Acids DHA and EPA May Prevent Eye Disease
Nutritional supplementation of omega-3-polyunsaturated fatty acids, particularly DHA and EPA, may prevent eye disease, report researchers from Harvard Medical School and the National Eye Institute.
Tuesday, June 12, 2007
Vitamin B Deficiency and Stroke Prevention: New Report Says Folic Acid Supplementation Can Reduce Risk of Stroke
A new meta-analysis by an international team of researchers has determined that folic acid supplementation can effectively reduce the risk of a first stroke by 18 percent.
Monday, April 16, 2007
Columbia University Medical Researchers Find Diabetes May Be Linked with Cognitive Impairment
It is no secret that diabetes is linked with cardiovascular disease: the American Diabetes Association reports more than 65% of people with diabetes die from heart disease or stroke.

Wednesday, January 24, 2007
Take Folic Acid for Brain Health
Dr. Jane Durga and colleagues from Wageningen University in the Netherlands published findings from a double-blind, placebo controlled study in the January 20 edition of The Lancet medical journal.
Tuesday, December 05, 2006
Take Heart: Study Validates Folic Acid Decreases Risk of Heart Disease and Stroke, Reinforces Animi-3 Formula
A new study in British Medical Journal* reviews the scientific evidence published in previous studies that supports the use of folic acid as a way of reducing the risk of heart disease and strokes.

Monday, November 20, 2006
New Study Shows DHA (Docosahexaenoic Acid) Cuts Risk of Dementia
A new follow-up study to the Framingham Heart Study has determined that DHA (docosahexaenoic acid) significantly decreases the risk of developing all-cause dementia by 47 percent.
Monday, September 25, 2006
New Study Finds Omega-3’s (DHA and EPA) in Fatty Fish Can Reduce Risk of Cancer
A new study conducted by scientists at the Karolinska Institutet in Sweden has found that eating fatty fish, which contains higher levels of DHA* and EPA** (omega-3’s) than lean fish, significantly decreases the risk of renal cell carcinoma (RCC) in women.

Wednesday, August 02, 2006
Tufts Researchers Find That Omega-3’s Can Reduce Risk Of Cardiovascular Disease
A comprehensive review of published clinical studies by research associates at Tufts-New England Medical Center has found that increased consumption of DHA* and EPA** (omega-3’s), "reduces the rates of all-cause mortality, cardiac and sudden death, and possibly stroke."
Friday, February 03, 2006
NIH Researcher Reports Omega-3 Fatty Acids—Such As Those In Animi-3 Rx—Are Essential For Mothers To Positively Impact Mental And Social Development Of Their Children
A new study by NIH researcher Joseph Hibbeln has found that omega-3 fatty acids taken by pregnant women have a discernible positive effect on the mental and social development of their children.
Wednesday, November 09, 2005
Animi-3® Clinical Trial for Cardiovascular Risk Reduction and Cognition Begins with Leading Medical Researcher from Tufts University
Animi-3® clinical trial for cardiovascular risk reduction and cognition begins with leading medical researcher from Tufts University.
Tuesday, November 08, 2005
Supplement for Reduction of Cardiovascular Disease on Trial
PBM Pharmaceuticals Inc. announced yesterday that it is conducting a clinical trial of the active supplement Animi-3®, designed to study the related cardiovascular risk reduction.

Sunday, October 10, 2004
Omega-3 Fatty Acids: Good for the Heart, and Good for the Brain
In Light of the FDA’s New “Black Box” Warning for Antidepressants, NewYork-Presbyterian/Weill Cornell Physician-Scientists Call for Further Investigation of Omega-3s

Sunday, July 04, 2004
Increased Consumption of Omega-3 Fatty Acids May Lower the Risk of Cardiovascular Disease, Dementia and Inflammatory Disease
Folic Acid, Vitamin B6 and Vitamin B12 Also May Lower the Risk of Cardiovascular Disease and Dementia by Decreasing the Levels of Homocysteine in the Blood

 

Prescribing Info Side Effects Free Voucher Availability Press Room PBM Pharmaceuticals


Animi-3 is indicated for improving nutritional status in conditions requiring DHA, Vitamin B12, B6, and folic acid supplementation.
Animi-3 is not intended to diagnose, treat, or cure any disease.